MedDataX Logo

Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone

NCT ID: NCT00662181

Last Updated: 2008-04-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

46 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-05-31

Study Completion Date

2009-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A follow-up study on the randomized, controlled, double-blind HIGH: low study. We will examine the participants from the HIGH: low study min. 6 months after finishing the HIGH: low study. We will look at the parameters: quality of life, sugar-metabolism, fat-metabolism, fat-redistribution and cytokines. The study will use the participants control visit, and the only additional examination will be the danish MOS-HIV questionnaire.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infections HIV-Associated Lipodystrophy Syndrome

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

growth hormone quality of life fat redistribution sugar metabolism fat metabolism cytokines

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

H, NH

HIV positive patients with and without lipodystrophy

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* over 18 years of age
* Participated in and completed the HIGH: low study
* informed consent signed

Exclusion Criteria

* Patient stopped at Hvidovre Hospital, or didn't finish the HIGH: low study
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hvidovre University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Klinisk Forskningscenter, Hvidovre Hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ove Andersen, MD

Role: PRINCIPAL_INVESTIGATOR

Klinisk Forskningcenter, Hvidovre Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Klinisk Forskningscenter, Hvidovre Hospital

Hvidovre, Hvidovre, Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Katrine MH Andersen, stud.med.

Role: CONTACT

Phone: 45-36-322-108

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Katrine Andersen, Stud.med.

Role: primary

Related Links

Access external resources that provide additional context or updates about the study.

http://www.hvidovrehospital.dk

The official website for Hvidovre Hospital

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2008-41-2145

Identifier Type: -

Identifier Source: secondary_id

H-B-2008-053

Identifier Type: -

Identifier Source: org_study_id